Filipino - Kiingereza - FDA (Food And Drug Administration)

metro drug, inc. - flupentixol (as dihydrochloride) - film-coated tablet - 1 mg

Singapoo - Kiingereza - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - flupentixol dihydrochloride eqv flupentixol; melitracen hydrochloride eqv melitracen - tablet, film coated - 0.5 mg - flupentixol dihydrochloride eqv flupentixol 0.5 mg; melitracen hydrochloride eqv melitracen 10 mg

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

lundbeck ( ireland ) limited - flupentixol decanoate - solution for injection - 20 milligram(s)/millilitre - thioxanthene derivatives; flupentixol

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

lundbeck ( ireland ) limited - flupentixol decanoate - solution for injection - 100 milligram(s)/millilitre - thioxanthene derivatives; flupentixol

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flupentixol decanoate 20 mg/ml - injection (depot) - 20 mg/ml - active: flupentixol decanoate 20 mg/ml excipient: vegetable oil - fluanxol injection is a depot neuroleptic preparation and is indicated in the treatment and maintenance of schizophrenic patients, especially those who are unreliable in taking the medicine prescribed for them.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flupentixol decanoate 100 mg/ml - injection (depot) - 100 mg/ml - active: flupentixol decanoate 100 mg/ml excipient: vegetable oil - fluanxol concentrated injection is a depot neuroleptic preparation and is indicated in the treatment of moderate to severe schizophrenia and allied psychoses. patients for whom the drug is especially appropriate are: 1. those believed by the physician to be unreliable in taking oral medication. 2. patients who are already receiving treatment with fluanxol injection at high dose levels and who may experience discomfort as a result of the large injection volume. 3. patients who hitherto could not receive effective treatment with depot neuroleptics because of the high doses, and hence large volumes, required to achieve satisfactory therapeutic blood levels. features of the illness most likely to benefit are hallucinations, paranoid delusions, apathy, inertia, withdrawal and anxiety

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lundbeck sa-nv - melitracen hydrochloride 11,25 mg - eq. melitracen 10 mg; flupentixol dihydrochloride 0,584 mg - eq. flupentixol 0,5 mg - film-coated tablet - 10 mg - 0,5 mg - flupentixol hydrochloride 0.584 mg; melitracen hydrochloride 11.25 mg - melitracen and psycholeptics

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

lundbeck limited - flupentixol decanoate - solution for injection - 200 micromol

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - flupentixol decanoate - solution for injection - 100mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - flupentixol decanoate - solution for injection - 100mg/1ml